Fever News and Research

RSS

NanoViricides' FluCide drug candidate greatly reduces lung viral load in animals

NanoViricides, Inc. reports that post-infection treatment with its optimized FluCide drug candidates achieved 1,000-fold reduction in the levels of infectious virus in the lungs of animals with a lethal level of influenza virus infection.

3 May 2011

South Australian man succumbs to Murray Valley Encephalitis

A 27-year-old South Australian Riverland man has succumbed to Murray Valley Encephalitis (MVE) – a viral disease that is carried by mosquitoes. According to SA Health's chief medical officer Paddy Phillips, the man had been receiving hospital care for MVE since March.

3 May 2011

Hospitals can implement preventive measures to reduce measles outbreak

The U.S. measles vaccination program has been successful in eliminating endemic measles in the United States; yet this success has provided challenges that require ongoing vigilance for the rapid identification and response to measles cases in health care settings.

2 May 2011

Study explores link between infants' daily growth and sleep

Science is finally confirming what grandma knew all along: infants wake up taller right after they sleep.

2 May 2011

Antiviral Drugs Advisory Committee recommends FDA to approve telaprevir for hepatitis C

Vertex Pharmaceuticals Incorporated announced that the Antiviral Drugs Advisory Committee to the U.S. Food and Drug Administration voted unanimously to recommend FDA approval of telaprevir for people with genotype 1 chronic hepatitis C.

29 Apr 2011

UIC receives federal contract to develop antibiotics against three bacterial infections

Researchers at the University of Illinois at Chicago's Center for Pharmaceutical Biotechnology have been awarded a federal contract for up to $13.8 million to develop antibiotics to treat anthrax, tularemia and plague.

28 Apr 2011

Researchers begin approved drugs screening for clinical use against rare diseases

Researchers have begun screening the first definitive collection of thousands of approved drugs for clinical use against rare and neglected diseases. They are hunting for additional uses of the drugs hoping to find off-label therapies, for some of the 6,000 rare diseases that afflict 25 million Americans.

28 Apr 2011

Clinical study: Plant extract can fight effectively against hay fever

Fighting hay fever with a plant extract - this works, as was shown in a clinical study conducted by researchers of the Center of Allergy & Environment of Helmholtz Zentrum München and Technische Universität München.

27 Apr 2011

Merck receives Health Canada approval for GARDASIL to treat HPV in women upto age 45

Today, Merck announced that Health Canada has extended the indication of GARDASIL in women up to the age of 45. Merck's HPV vaccine is now approved for girls and women nine through 45 years of age for the prevention of cervical cancer, vulvar and vaginal cancers, precancerous lesions and genital warts caused by the Human Papillomavirus types 6, 11, 16, 18. Previously, GARDASIL was approved in girls and women nine through 26.

26 Apr 2011

Survey: Pharmacists top OTC product picks in more than 77 total categories

The 2010 Pharmacy Today Over-the-Counter Product Survey, conducted by the American Pharmacists Association, reveals pharmacists believe that 81% of consumers purchase the over-the-counter product that was recommended by their pharmacist, 92% of pharmacists walk a patient to the OTC section to assist with a product selection and the average patient consult takes only three minutes of the patient's time.

26 Apr 2011

GSK receives FDA approval for Lamictal XR to treat partial seizures

GlaxoSmithKline announced today that the U.S. Food and Drug Administration has approved Lamictal XR Extended-Release Tablets for conversion to monotherapy in patients 13 years and older with partial seizures taking one anti-epileptic drug.

26 Apr 2011

Scientists develop new low cost test for acute pancreatitis

A new low cost test for acute pancreatitis that gets results much faster than existing tests has been developed by scientists at The University of Texas at Austin.

26 Apr 2011

Viewpoints: Sebelius on medical mistakes; Stockman on solving deficit; Fox on Medicare's political history

A recent study found that as many as one out of three hospital patients is harmed by his or her care. And the Institute of Medicine estimates that as many as 100,000 Americans die each year from preventable medical errors in hospitals. That's about the number of annual deaths caused by auto accidents, AIDS, and breast cancer combined.

26 Apr 2011

Rwanda, QIAGEN and Merck launch comprehensive national cervical cancer prevention program

The Government of Rwanda, together with QIAGEN N.V. and Merck, known as MSD outside the United States and Canada, today announced the launch, in Kigali, Rwanda, of a comprehensive national cervical cancer prevention program that includes vaccination with GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] for appropriate girls 12 to 15 years of age and modern molecular diagnostic screening for women between the ages of 35 and 45.

From QIAGEN Manchester Limited 25 Apr 2011

AstraZeneca announces U.S. availability of vandetanib for rare medullary thyroid cancer

AstraZeneca today announced that the orphan drug vandetanib is now available to U.S. patients for the treatment of medullary thyroid cancer that cannot be removed by surgery or that has spread to other parts of the body.

25 Apr 2011

Ahead of Immunization Week, WHO calls for countries to come together to control measles outbreak in Europe

WHO is urging countries in Europe to join together to help control the measles outbreak that has grown to more than 6,500 cases in 33 countries and the potential for worsening outbreaks "in the days ahead as people travel during the Easter holidays," U.N. News Centre reports.

25 Apr 2011

Sanofi Pasteur receives FDA approval for Menactra to prevent meningococcal disease

The U.S. Food and Drug Administration today approved the use of Menactra in children as young as 9 months for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135. Menactra already is approved for use in people ages 2 through 55 years.

24 Apr 2011

'Iceman' influences autonomic nervous system and immune response

At the Radboud University Nijmegen Medical Centre, professor of experimental intensive care medicine dr. Peter Pickkers and his team have performed research on "Iceman" Wim Hof. Hof claims that he can influence his autonomic nervous system and immune response through concentration and meditation.

22 Apr 2011

Researchers discover new compound to fight against shingles

Researchers at the University of Georgia and Yale University have discovered a compound with the potential to be more effective than existing agents in treating the very painful blisters known as shingles-a condition that affects up to 30 percent of Americans, mostly elderly, and for which no specific treatment exists.

22 Apr 2011

Salix Pharmaceuticals receives three U.S. patents relating to rifaximin

Salix Pharmaceuticals, Ltd. today announced that the U.S. Patent and Trademark Office has issued three patents relating to rifaximin.

21 Apr 2011

Fever News and Research

NanoViricides' FluCide drug candidate greatly reduces lung viral load in animals

South Australian man succumbs to Murray Valley Encephalitis

Hospitals can implement preventive measures to reduce measles outbreak

Study explores link between infants' daily growth and sleep

Antiviral Drugs Advisory Committee recommends FDA to approve telaprevir for hepatitis C

UIC receives federal contract to develop antibiotics against three bacterial infections

Researchers begin approved drugs screening for clinical use against rare diseases

Clinical study: Plant extract can fight effectively against hay fever

Merck receives Health Canada approval for GARDASIL to treat HPV in women upto age 45

Survey: Pharmacists top OTC product picks in more than 77 total categories

GSK receives FDA approval for Lamictal XR to treat partial seizures

Scientists develop new low cost test for acute pancreatitis

Viewpoints: Sebelius on medical mistakes; Stockman on solving deficit; Fox on Medicare's political history

Rwanda, QIAGEN and Merck launch comprehensive national cervical cancer prevention program

AstraZeneca announces U.S. availability of vandetanib for rare medullary thyroid cancer

Ahead of Immunization Week, WHO calls for countries to come together to control measles outbreak in Europe

Sanofi Pasteur receives FDA approval for Menactra to prevent meningococcal disease

'Iceman' influences autonomic nervous system and immune response

Researchers discover new compound to fight against shingles

Salix Pharmaceuticals receives three U.S. patents relating to rifaximin

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News